Cost-effectiveness analysis in oncology

被引:36
作者
Earle, CC
Coyle, D
Evans, WK
机构
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Ottawa, ON K1N 6N5, Canada
关键词
cancer; cost; cost analysis; cost-effectiveness; health economics; pharmacoeconomics;
D O I
10.1023/A:1008292128615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Physicians are faced with a burgeoning literature of economic studies. However, most physicians have little training in evaluating economic research. Economic studies involve a comparison of the costs and benefits of alternative treatment options. To be of use for medical decision making, they should meet appropriate methodological standards. These include clear specification of the research question and the perspective from which the study is being undertaken, comparison of relevant treatment options. identification and quantification of all important costs and benefits, the use of discounting to allow for time preferences for costs and benefits, and sensitivity analyses to test the robustness of the study's results. Unfortunately, not all adhere to these principles. Physicians need to be able to understand and critically assess the quality of economic studies, and the applicability of the results to their own situation, in order to participate in medical policy decisions.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 41 条
[21]   STAGING OF LUNG-CANCER - A COST-EFFECTIVENESS ANALYSIS [J].
HOUSTON, GA ;
SANDERS, JA ;
LITTLE, DD ;
GRIFFITH, JE ;
CLERICUZIO, C ;
BALDUCCI, L .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (03) :224-230
[22]   COUNTING THE COSTS OF CHEMOTHERAPY IN A NATIONAL-CANCER-INSTITUTE-OF-CANADA RANDOMIZED TRIAL IN NONSMALL-CELL LUNG-CANCER [J].
JAAKKIMAINEN, L ;
GOODWIN, PJ ;
PATER, J ;
WARDE, P ;
MURRAY, N ;
RAPP, E .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1301-1309
[23]   A MODEL FOR CALCULATING THE COSTS OF IN-VIVO DOSIMETRY AND PORTAL IMAGING IN RADIOTHERAPY DEPARTMENTS [J].
KESTELOOT, K ;
DUTREIX, A ;
VANDERSCHUEREN, E .
RADIOTHERAPY AND ONCOLOGY, 1993, 28 (02) :108-117
[24]  
Kesteloot K, 1993, Int J Technol Assess Health Care, V9, P274
[25]   INDIRECT COSTS IN ECONOMIC-STUDIES - CONFRONTING THE CONFUSION [J].
KOOPMANSCHAP, MA ;
RUTTEN, FFH .
PHARMACOECONOMICS, 1993, 4 (06) :446-454
[26]  
LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473
[27]   THE DESIGN OF FUTURE COST-BENEFIT STUDIES [J].
MAYNARD, A .
AMERICAN HEART JOURNAL, 1990, 119 (03) :761-765
[28]   DEVELOPING THE HEALTH-CARE MARKET [J].
MAYNARD, A .
ECONOMIC JOURNAL, 1991, 101 (408) :1277-1286
[29]  
OBrien BJ, 1997, JAMA-J AM MED ASSOC, V277, P1802
[30]  
*ONT MIN HLTH, 1991, GUID PREP EC AN SUBM